Addressing Neglected Disease

Addressing Neglected Disease

11.28.11 | By

I wanted to bring to your attention a recent piece by Sarika Bansal in Forbes. Ms. Bansal's piece is entitled "Top Five Ways Big Pharma Can Address Neglected Disease." As well as making some good observations about what is needed in the effort to address neglected diseases around the world, she also does a good job of acknowledging many things that biopharmaceutical research companies are already doing. In the last decade, the research-based pharmaceutical industry spent more than $9.2 billion to help in the fight against neglected diseases.
Read the Forbes piece here. Find out more about what global biopharmaceutical research companies are doing to help in the fight against neglected diseases here.

More On PhRMA — powered by PhRMApedia


Cost in Context